JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.095x

Based on the latest financial reports, JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) has a cash flow conversion efficiency ratio of 0.095x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.62 Billion ≈ $39.19 Million USD) by net assets (Rs38.06 Billion ≈ $411.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See JBCHEPHARM defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

JB Chemicals & Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2006–2026)

This chart illustrates how JB Chemicals & Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

JB Chemicals & Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of JB Chemicals & Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Cleanaway Waste Management Ltd
AU:CWY
0.060x
Shanghai Phichem Material Co Ltd Class A
SHE:300398
0.030x
Changchun High & New Technology Industries Group Inc
SHE:000661
-0.020x
Graham Holdings Co
NYSE:GHC
0.014x
Sam Chun Dang Pharm. Co. Ltd
KQ:000250
-0.043x
PT Alamtri Resources Indonesia Tbk
JK:ADRO
0.051x
ShenZhen Special Economic Zone Real Estate & Properties Group Co Ltd
SHE:000029
-0.001x
Constellium SE
F:3OK
0.064x

Annual Cash Flow Conversion Efficiency for JB Chemicals & Pharmaceuticals Limited (2006–2026)

The table below shows the annual cash flow conversion efficiency of JB Chemicals & Pharmaceuticals Limited from 2006 to 2026. For the full company profile with market capitalisation and key ratios, see market value of JB Chemicals & Pharmaceuticals Limited.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs41.59 Billion
≈ $449.80 Million
Rs7.11 Billion
≈ $76.85 Million
0.171x -35.00%
2025-03-31 Rs34.33 Billion
≈ $371.30 Million
Rs9.02 Billion
≈ $97.60 Million
0.263x -4.02%
2024-03-31 Rs29.23 Billion
≈ $316.15 Million
Rs8.01 Billion
≈ $86.58 Million
0.274x +8.58%
2023-03-31 Rs24.80 Billion
≈ $268.24 Million
Rs6.26 Billion
≈ $67.66 Million
0.252x +217.05%
2022-03-31 Rs21.39 Billion
≈ $231.28 Million
Rs1.70 Billion
≈ $18.40 Million
0.080x -54.17%
2021-03-31 Rs18.13 Billion
≈ $196.12 Million
Rs3.15 Billion
≈ $34.04 Million
0.174x -9.35%
2020-03-31 Rs14.38 Billion
≈ $155.51 Million
Rs2.75 Billion
≈ $29.78 Million
0.191x +47.08%
2019-03-31 Rs14.83 Billion
≈ $160.37 Million
Rs1.93 Billion
≈ $20.88 Million
0.130x +52.83%
2018-03-31 Rs14.44 Billion
≈ $156.20 Million
Rs1.23 Billion
≈ $13.31 Million
0.085x -41.88%
2017-03-31 Rs13.66 Billion
≈ $147.71 Million
Rs2.00 Billion
≈ $21.65 Million
0.147x +14.95%
2016-03-31 Rs10.95 Billion
≈ $118.46 Million
Rs1.40 Billion
≈ $15.10 Million
0.128x +0.15%
2015-03-31 Rs9.95 Billion
≈ $107.59 Million
Rs1.27 Billion
≈ $13.70 Million
0.127x +1049.86%
2014-03-31 Rs10.43 Billion
≈ $112.78 Million
Rs-139.78 Million
≈ $-1.51 Million
-0.013x -116.10%
2013-03-31 Rs10.20 Billion
≈ $110.34 Million
Rs849.32 Million
≈ $9.19 Million
0.083x -90.82%
2012-03-31 Rs9.70 Billion
≈ $104.90 Million
Rs8.80 Billion
≈ $95.14 Million
0.907x +368.67%
2011-03-31 Rs6.92 Billion
≈ $74.79 Million
Rs1.34 Billion
≈ $14.47 Million
0.194x -9.87%
2010-03-31 Rs5.68 Billion
≈ $61.44 Million
Rs1.22 Billion
≈ $13.19 Million
0.215x +10.50%
2009-03-31 Rs4.69 Billion
≈ $50.71 Million
Rs911.05 Million
≈ $9.85 Million
0.194x +210.91%
2008-03-31 Rs4.53 Billion
≈ $48.99 Million
Rs283.11 Million
≈ $3.06 Million
0.062x +17.36%
2007-03-31 Rs4.18 Billion
≈ $45.26 Million
Rs222.82 Million
≈ $2.41 Million
0.053x -21.99%
2006-03-31 Rs3.30 Billion
≈ $35.73 Million
Rs225.51 Million
≈ $2.44 Million
0.068x --

About JB Chemicals & Pharmaceuticals Limited

NSE:JBCHEPHARM India Drug Manufacturers - Specialty & Generic
Market Cap
$3.82 Billion
Rs352.99 Billion INR
Market Cap Rank
#4310 Global
#185 in India
Share Price
Rs2198.50
Change (1 day)
+0.13%
52-Week Range
Rs1614.40 - Rs2257.70
All Time High
Rs2257.70
About

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; and nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dos… Read more